Sequent Scientific Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 14,128.16 million compared to INR 13,616.15 million a year ago. Revenue was INR 14,236.61 million compared to INR 13,699.78 million a year ago. Net income was INR 412.51 million compared to INR 954.42 million a year ago. Basic earnings per share from continuing operations was INR 1.67 compared to INR 3.87 a year ago. Diluted earnings per share from continuing operations was INR 1.65 compared to INR 3.85 a year ago.